Table 2. Univariate analyses of sensitivity to chemoradiotherapy in ESCC patients.
Factor | N | Responder | Resistance | Chi-square | p value |
---|---|---|---|---|---|
Age | |||||
≤60 | 32 | 22 | 10 | 0.523 | 0.505 |
>60 | 136 | 102 | 34 | ||
Sex | |||||
Male | 134 | 100 | 34 | 0.229 | 0.665 |
Female | 34 | 24 | 10 | ||
Smoking | |||||
No | 72 | 42 | 30 | 15.611 | <0.001 |
Yes | 96 | 82 | 14 | ||
Tumour site | |||||
Upper 1/3 | 60 | 54 | 10 | 5.979 | 0.05 |
Middle 1/3 | 78 | 50 | 24 | ||
Lower 1/3 | 30 | 20 | 10 | ||
T stage | |||||
II/III | 130 | 98 | 32 | 0.738 | 0.390 |
IV | 38 | 26 | 12 | ||
N stage | |||||
0 | 44 | 34 | 10 | 0.370 | 0.690 |
I | 124 | 90 | 34 | ||
Clinic stage | |||||
II | 44 | 34 | 10 | 17.811 | <0.001 |
III | 86 | 70 | 14 | ||
IV | 38 | 18 | 20 | ||
Adjuvant therapies | |||||
RT | 46 | 30 | 16 | 2.419 | 0.167 |
CCRT | 122 | 94 | 28 | ||
NLR | |||||
≤3.34 | 108 | 88 | 20 | 9.207 | 0.003 |
>3.34 | 60 | 36 | 24 | ||
PLR | |||||
≤103.75 | 68 | 58 | 10 | 7.795 | 0.005 |
>103.75 | 100 | 66 | 34 | ||
CNP | |||||
0 score | 64 | 64 | 10 | 15.283 | <0.001 |
1 score | 48 | 38 | 10 | ||
2 score | 56 | 32 | 24 | ||
Hemoglobin level | |||||
≤43.98 | 80 | 50 | 30 | 10.105 | <0.001 |
>43.98 | 88 | 74 | 14 |